KUALA LUMPUR (March 22): Rakuten Trade has a 'buy' rating for Alpha IVF Group Bhd at an initial public offering (IPO) price of 32 sen, with a fair value (FV) of 34 sen, and said Alpha is currently in a net cash position with RM27.5 million and has healthy cash flow generation capabilities.
In a note on Friday, the research house said it expects Alpha to pay a dividend of 0.7 sen for the financial year ending May 31, 2024 (FY2024), translating into a yield of 2.1%, and a dividend of 0.8 sen for FY2025, a yield of 2.5%.
“We expect Alpha to register core net earnings of RM53.8 million for FY2024, and RM65.5 million for FY2025.
“[We recommend] 'buy' with an FV of 34 sen, based on 25 times FY2025 earnings per share, which aligns with healthcare service providers [listed on Bursa Malaysia],” Rakuten said.
Read also:
Alpha IVF opens flat at 32 sen on ACE Market debut
Alpha IVF signs underwriting agreement for largest ever ACE Market IPO
ACE Market-bound Alpha IVF posts 2Q net profit of RM12m
Public portion of Alpha IVF's IPO oversubscribed by 1.73 times
PublicInvest Research values ACE Market-bound Alpha IVF at 38 sen